Cartesian Therapeutics, Inc.
Descartes-08
myositis
Countdown
358days
Phase 2 readout · ~ Jun 30, 2027 estimated
What's at stake
Phase 2 trial results for Descartes-08 in myositis are due ~ Jun 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“data from a subset of patients from the trial in the first half of 2027”